Finding 611003 (2022-001)

- Repeat Finding
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2023-03-21
Audit: 31104
Organization: Kennedy Krieger Institute (MD)

AI Summary

  • Core Issue: The Company misreported its lost revenues by claiming to use Option (i) instead of the actual Option (iii) in its PRF submissions.
  • Impacted Requirements: This misreporting violates the June 11, 2021 PRF reporting guidelines, leading to potential compliance issues.
  • Recommended Follow-Up: The Company should reach out to HRSA for guidance on necessary corrective actions due to the incorrect reporting.

Finding Text

2022-001: Lost Revenues Reporting Methodology Cluster: Not applicable Federal Granting Agency: Health Resources and Services Administration Award Name: COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution ? Period 2 Assistance Listing #: 93.498 Assistance Listing Title: COVID-19 Provider Relief Fund and American Rescue Plan (ARP) RuralDistribution ? Period 2 Award Year: January 1, 2020 ? June 30, 2022 Criteria Step Six of the Steps on Reporting on Use of Funds section of the June 11, 2021 Provider Relief Fund(PRF) General and Targeted Distribution Post-Payment Notice of Reporting Requirements requires recipients that apply PRF payments toward lost revenues to use one of the following three options for calculating lost revenues: ? Option (i): difference between actual patient care revenues; ? Option (ii): difference between budgeted (prior to March 27, 2020) and actual patient carerevenues; or ? Option (iii): calculated by any reasonable method of estimating revenues Condition The Company calculated the portion of its Period 2 PRF payments applied toward lost revenues usingOption (iii); however, the Company completed its Period 2 PRF Reporting Portal submissions and attested to calculating lost revenues using Option (i). Cause The Company did not interpret the HRSA PRF Reporting instructions correctly therefore attested to usingOption (i) in its Period 2 PRF Reporting Portal submissions. Effect The Company incorrectly attested to the methodology utilized to calculate lost revenue in accordance withthe June 11, 2021 PRF General and Targeted Distribution Post-Payment Notice of Reporting Requirements. In addition, as required by the Health Resources & Services Administrator (HRSA) when Option (iii) is utilized, information used to support the methodology used was not provided to HRSA when the portal reporting was submitted. This is a repeat finding from the prior year. Questioned Costs None noted. Recommendation We recommend the Company contact the Health Resources & Services Administrator (HRSA) to determine any required corrective actions related to the incorrect reporting. Management?s Views and Corrective Action Plan Management?s response is included in ?Management?s Views and Corrective Action Plan? included at the end of this report.

Categories

Reporting

Other Findings in this Audit

Programs in Audit

ALN Program Name Expenditures
12.750 Reliable Sensor Technology-Based for Rehabilitation $962,700
93.110 McH Training Program in Neurodevelopment Disabilities $712,922
93.632 Developmental Disabilities $577,352
84.324A Development of An Intervention for Center-Based Early Childhood Education $460,945
93.600 Early Head Start Center $431,405
93.286 Novel Approaches for Cest Labeling, Detection, Quantification and Translation $427,422
93.994 Within My World $399,842
93.255 Children's Hospital Graduate Medical Education $387,713
93.837 Mri Based Phosphocreatine Mapping Method to Assess Patients with Peripheral Arterial Disease $352,360
93.242 Anomalous Motor System Physiology in Adhd $314,143
93.243 Collective for Antiracist Child and Family Systems $288,431
93.600 Pact Ehs Therapeutic Nursery $250,504
16.575 Underserved Victims Project $227,664
93.279 Healthy Brain & Child Development National Consortium $222,078
93.853 Chromatin Modifications in Gbm-Propagating Cells $212,196
93.242 Behavioral and Neural Representations of Subjective Effort Cost $211,553
93.286 Development and Translation of D-Glucose As A Diagnostic Agent for Mri $210,147
93.000 Therapeutic Nursery $200,691
84.027 Providing Technical Assistance to the Eastern Shore of Maryland $199,786
84.324A Developing Early Achievements for Pre-K Children with Developmental Language Disorders $193,836
93.286 Resource for Molecular Imaging Agents in Precision Medicine $181,681
93.351 Magnetic Particle Imaging Scanner $180,000
93.286 Gastric Electrical Slow Wave Functional Mri of the Human Brain $178,100
93.242 Neurobiology of Social Behavior Circuit Analysis in Early Life $177,927
93.853 Gabaergic Sensorimotor Dysfunction in Tourette Syndrome $168,528
93.137 Emurg for Health Equity Leaders Fellowship Program $161,017
93.865 Preparing for A Clinical Trial in Kabuki Syndrome $160,944
93.853 In Vivo Assessment of Meningeal Inflammation and It's Clinical Impact in Ms $139,642
93.865 Mechanism & Rehabilitation of Cerebella Ataxia $133,881
93.853 Utility of Advanced Mri & Wearable Technology to Identify Lbsl $133,852
93.865 Subtle Motor Functioning and Functional Connectivity in Youth After Mild Tbi $133,140
93.310 An Asf Enriched Risk Echo Cohort $128,644
93.994 Enhancing Child Care for Children $125,530
93.994 Project Stir $124,050
93.865 Mechanisms Regulating Kcc@ Hypofunction $122,543
93.866 Biomarkers of Cognetive Decline Among Normal Individuals $116,397
93.242 Neural Mechanisms of Hiv Associates Cns Dysfunction $109,706
93.847 Developing Mri Contrast Agents to Detect Progression in Renal Disease $108,970
47.040 Multimodal Algorithms for Notor Imitation Assesment in Autism $108,931
93.394 Noninvasive Prediction of Tumor Response to Gemcitabine Using Mri $105,094
93.837 Non-Contrast-Enhanced Velocity-Selective Mr Angiography $104,504
93.865 Measuring Altered Glutathione in Children with Austism $95,983
93.286 Sensitivity Enhanced Mri Imaging of Receptor Binding in Breast Cancer $94,889
93.394 Quantitative Cest Mri for Gbm Ealry Response Prediction and Biopsy Guidance $94,001
93.837 Mri Bimodal Imaging for Non Invasive Tracking of Extracellular Vesicles $92,073
93.242 Somatossensory Inhibitory Dysfunction in Austism Spectrum Disorder $90,287
93.853 Preclinical Stroke Trial with the Parp Inhibitor Veliparib $89,084
93.279 Developing Plans for A Baltimore Site If the Healthy Bcd Study $89,058
84.425R Covid-19: Coronavirus Response & Relief Supplemental Appropriations Act - Geer $86,748
93.837 Velocity-Selective Arterial Spin Labeling Based Perfusion Mapping for Cerebrovascular Diseases $84,000
93.434 Promoting Positive Outcomes for Infant & Toddlers $81,563
93.630 Enhancing Advocacy & Public Policy Work Project $81,476
93.307 Social Adversities, Epigenetics and the Obesity Epidemic $79,970
93.837 Computational Assessment of Galectin-3 Significance in Heart Failure $78,942
93.853 Molecular Determinanats of Cellular Heteroeneity and Theapeutic Resistance in Gbm $78,595
83.837 Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest $76,723
93.853 Child Neurologist Career Development Program $75,135
93.853 The Global Leukodystrophy Initiative Clinical Trials Network $74,867
93.866 Impaired Cerebral Glucose Uptake in the Brain As An Mri Marker for Alzheimer's Disease $74,277
93.866 Brain Oxygen Consumption As An Mri Biomarker $73,181
93.242 Motion-Robust Brain Mri for Infants $72,888
10.555 School Lunch Program $71,513
93.846 Brittle Bone Disorders Consortium of the Rare Disease Clinical Network $70,991
93.853 Development of Mechanisms Underlying Human Motor Learning $70,897
93.310 Supporting the Health & Well-Being of Children with Intellectual & Developmental Disability During Covid $69,734
93.394 Amide Proton Transfer Mri of Brain Tumors at 3t $69,620
93.310 Environmental Influences on Child Health Outcomes $68,985
93.395 Gene Delivery Nanoparticles to Treat Glioblastoma $68,132
12.420 Assessing Arrhythmic Risk in Adult Patients with Duchenne Muscular Dystrophy $64,114
93.853 Imaging Brain Glucose Uptake by in Vdmp Mri in Huntington's Disease $63,977
12.420 Randomized Trial of Telehealth Parent-Implemented Intervention $59,673
93.839 Clinical and Neuroimagin Phenotypes of Neurological Disorders in Pediatric Sickle Cell Disease $59,273
93.853 Advanced Mri Biomarkers in Hd Mouse Models Translatable to Humans $58,824
93.498 Covid-19: Provider Relief Fund & American Rescue Plan (arp) Rural Distribution $58,327
93.853 Advanced Mri Studies of Cerebrovascular & Lymphatic Abnormalities $56,720
93.866 Transcranial Direct Current Stimulation on Typical & Atypical Alzheimer's Disease $54,716
93.853 Extramural Research Programs in the Neurosciences Disorders $52,144
84.181A Baltimore City Infants & Toddlers Program $51,582
93.397 Non-Invasive Tracking of Genome-Corrected Ips Cells in Als $50,142
93.853 Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury $48,126
93.600 Pact Ehs Therapeutic Nursery - Covid 19 Fund $47,921
93.847 Impact of Hypothalamic Gliosis on Appetite Regulation & Obesity Risk $44,740
12.420 Alzheimers Research Program $44,602
93.395 Image-Guided Combotherapies for Radiotherapy Induced Neurocognitive $42,959
93.866 Non-Contrast Mr Imaging of Blood-Brain-Barrier Permeability in Alzheimer's Disease $40,994
93.866 Contributions of Local Cerebral Iron to Cognitive Decline During Aging and Preclinical Alheimer's Disease $40,540
93.273 Stress and Chronic Alcohol Interactions $39,827
93.994 Genetics Laboratory $38,329
12.420 Mapping of Brain Gaba Levels in Tuberous Sclerosis Complex Using High-Resolution Proton Imaging $37,079
93.839 Neuroimaging, Neurogognitive & Plasma Pretein Markers in Sickle Cell $36,928
93.242 Visual Hallucinations & Memory Impairment in Parkinson's Disease $36,572
93.632 Covid-19: Expanding Disabilities Networks Access to Covid 19 Vaccines $36,499
93.242 Adolescent Changes in Brain and Behavior in Boys and Girls with Adhd $36,077
93.865 Early Childhood Constraint Therapy for Sensory Impairment $36,023
93.286 Intracellular Self-Assembly of Theranostic Nanoparticles for Imaging $35,686
93.732 Behavioral Health Workforce Education and Training Program $35,290
93.631 Center for Dignity in Heakthcare for People with Disabilities $35,244
93.242 A Novel Framework for Impaired Imitation in Asd $35,154
93.853 Biomarkers of Brain Injury in Criticlly Ill Children on Extracorporeal Membrance Oxygenation Ecmo $35,019
93.866 Advanced Mr Imaging of Olfactory Impairment in Prodromal Alzheimers Disease $34,838
93.866 Jh Alzheimer's Disease Research Center $34,830
93.421 Covid 19: Addressing Covid-19 Vaccine Access and Confidence Among People with Disabilites $34,423
93.243 Pediatric Integrated Care Collabrative $34,301
93.865 Adult Biomarkers in Neonatal Brain Injury $34,256
93.242 Examinatin of Developmental Trajectories of Cognitive, Motor, & Emotional Control $33,321
93.853 Development of Novel Functional Markers for Tbi Using Molecular Mri $32,478
93.853 Development of Mri Microvascular Biomarkers in Cognitive Impairment and Dementia $30,958
93.853 Paracrine Angiotensin II Signaling Promotes Medulloblastoma $29,885
93.853 Modeling Host Susceptibility Factors in Acute Flaccid Myelitis $29,224
93.242 Visual-Motor Development in Infants at High Risk for Autism $28,417
93.073 Centers for Autism & Developmental Disabilities Research $27,998
93.866 Towards A Comprehansive Neurometabolic Profile in Patients W/ Mild Cognitive Impairment $26,366
93.853 The Role of Ranbp2 in the Pathogenesis of Acute Encephalopathy $25,323
93.456 Maternal Child Health Careers/research Initatives-Undergrad $24,948
93.853 A Placebo Controlled Effectivemess in Inph Shunting Trial $24,865
93.110 McH Research $24,534
93.853 Cortical Functional Connectivity As An Early Biomarker of Recovery in Sci $24,013
93.865 Resident Training in Brain Injury Rehab $23,179
93.853 A Safety and Efficacy Study of Aava-Haadc $23,115
93.853 Targeting Hyaluronan-Mediated Motility Receptor in Glioblastoma Stem Cells $23,112
93.676 Residential Shelter Care & Fingerprinting Services $22,826
10.553 School Breakfast Program $22,537
93.242 Solving the Mri Motion Problem with Framewise Integrated Real Time Mri Monitoring Software $22,479
93.853 Extramural Research Programs in the Neuro Disorders $22,113
93.853 Imaging Neurodegeneration in Ms $20,979
12.420 Identifying the Underlying Mechanisms of Persistent Neurologic Symptoms $19,845
93.866 Blood Brain Barrier Dysfunction in Alzheimers Disease $19,755
93.394 Precision Magnetic Hypertermia by Integrating Magnetic Particle $19,026
93.853 Meaningful Outcomes & Multisite Readiness for Clinical Trials in Juvenile Neuronal Ceriod Lipofuscinosis $18,302
93.310 Wuiddrc and Kki Safe Return to School $18,202
93.865 Subjective Valuation of Ohysical Effort in Health and Disease $17,581
93.866 Developing Protein-Based Biomarkers for Alzheimer's Disease $17,148
93.866 Longitudinal Molecular Imaging of Neuropathology $15,384
93.865 Csa As A Preventable Public Health Problem $14,594
93.853 Move - Modeling of Fast Movement for Enhancement Via Neuroprosthetics $14,572
93.394 A Wireless Multi-Function Microscope for Lifetime Imaging of the Brain Tumor Vasculome $14,477
93.853 Tet2 Regulation and Function in Glioma Cell Phenotype Reprogramming $14,164
93.865 Intellectual and Developmental Disablities Research Centers 2013 $14,056
93.853 Targeted Therapies for Neonatal White Matter Injury $13,301
93.865 Identifying Precursors to Severe Problem Behavior $13,300
93.575 Child Care Stabilization Funds American Rescue Plan $13,032
93.286 Chemical Exchange Satuation Transfer Mr Fingerprinting $12,758
84.173 Pact: World of Care Child Care Center $12,665
93.853 Characterization & Validation of Cvr As A Biomarker $12,516
93.853 Clinical Readiness to Solve Barriers to Drug Development in Fshd $12,450
21.027 Covid-19: Providing Emergency Relief for Community Providers of Services to Individuals with Disablities - Covid $12,363
93.310 Non-Invasive Tracking of Genome-Corrected Ips Cells in Als $12,358
84.027 State Grant - B - Kodem Kol $12,000
47.041 Discovering Network Structure in the Space of Group Level Functional Differences $11,888
93.600 Southeast Baltimore Ehs $11,883
84.173 Pact: Helping Children W/special Needs Therapeutic Nursery -YMCA $11,639
93.865 The Role of Executve Functions in Reading and Remediation $11,262
93.286 Mri Resource for Physiologic, Metabolic & Anatomic Biomarkers $10,893
21.027 2021 Balt Nonprofit Relief Fun $10,000
93.866 Altered Ph in Early Alzheimers Disease Detected by Creatine $9,440
93.853 Development of An Mri Template & Neuroimaging Biomarkers $8,647
84.424A Covid-19: Building School Psychologist's Knowledge, Skills, and Practice to Support Education - Covid $8,455
93.073 Study to Explore Early Development $8,292
93.853 Imaging Small Blood and Lympahtic Vessel Abnormalities $8,092
93.866 Alzheimer's Disease Neuroimaging Initiative $7,595
93.866 Contribution of Cerebral Iron Load to Elderly Individuals with High Risk for Alzheimers $7,578
93.286 Resources for Quantitive Functional Mri $7,069
93.853 Trial Readiness in Cavernous Angiomas and Symtomatic Hemmorage $6,845
93.310 Illuminationg Brain Function During Imitation in Children with Asd $6,764
93.286 Multi-Voxel Spectral Editing at 3t $6,521
93.866 Phase Ll/lll Trial for Slowing Progression in Mild Cognitive Impairment $6,504
93.242 Brain Glutomine Metabolism in Schizophrenia $5,540
93.865 Mri Biosensors and Complementary Drug Nonocarriers for Effective Image Guided Drug Delivery $5,097
93.853 Analysis of Dars2 in Leukoencephalopathy with Brainstem $4,949
12.420 Neurovascular Changes Associated with Olfactory Deficits in Early Parkinson's Disease $4,843
93.113 Investigating Air Pollution Effects on the Developing Brain and Asd $4,830
93.286 Neurodegenerative and Neurodevelopmental Subcortical Shape Diff $4,626
93.877 Ut2 Autism Intervention Research $4,584
93.242 Oxidative Stree and Bipolar Disorder Trajectories $4,572
93.173 Research Related to Deafness & Communication Disorders $4,390
93.866 Mechanism of Pathologic Tau Fibrils Neuron to Neuron Transmission $4,365
93.866 Heterochronic Blood Exchange Inhibits Synucleinopathy $4,210
93.866 Neural Network Connectivity of Financial Capacity in Mild Cognitive Impairment $3,780
93.866 Early Onset Ad Consortium - Leads $3,402
93.350 Johns Hopkins Institute for Clinical Translational Research $3,261
93.837 Non-Contrast Enhanced Peripheral Mr Angiography $3,064
93.839 Mri-Based Quantitative Brain Oximetry for Sickle Cell Disease $1,912
93.242 Investigation of Cerebullar Involvement in Cognitive Function $1,909
93.853 Lymphocyte Cpg Methylation Changes and Brain Pathology in Restless Leg Syndrome $1,701
93.865 The Role of Executive Functions in Reading & Reading Remediation $1,492
93.242 Feasibility, Acceptability, and Preliminary Efficacy Ot Text4father for Improving Infant & Family Health $1,241
93.847 Dorsomedial Hypothalamic Signaling Pathways & Energy Balance $1,134
93.279 Drug Abuse & Addiction Research Program $1,094
93.865 Reliable Sensor Technology-Based for Rehabilitation $432
84.324A Efficacy Trial of Early Achievements Comp Intervention Preschoolers with Autism $355
84.419 Preschool Development $250
93.243 Family Informed Trauma Treatment Ctr-Fitt $190
93.865 Delineating Subypes of Self-Injurious Behavior Maintained by Automatic $188
93.853 Development of Dendrimer N Acctylcysteine for the Treatment of Neonatal Brain Injury $145
93.242 Virtual Brain Electrode (vibe) for Imaging Neuronal Activity $-56
93.853 Targeting Taz-Driven Oncogenic Signaling in Medulloblastoma $-64
32.006 Covid-19 - Telecommunications and Equipment $-512
93.865 Biomarkers for Therapy of Fshd (u54) $-1,282
93.286 Simultaneous Hadamard Editing of Gaba and Glutathione $-1,555
93.846 Functional & Molecular Properties of Pax7 $-4,226
93.853 Targeted Therapies for Rett Syndrome $-4,616
93.394 Highly Accelerated Chemical Exchange Saturation Transfer Mri Using Compresse Sensing $-7,296
93.865 Human Locomotors Plasticity in Health and Disease $-12,435
93.853 Methyl-Cpg-Dependent Transcription Factor Function in Human Glioma $-12,449
93.866 Leveraging Energetics to Improve Gait Rehabilitation After Stroke $-14,947
93.853 Cerebrovascular Abnormalities in Huntingtons Disease $-25,848